Debanjana Chatterjee

Stock Analyst at Jones Trading

(3.71)
# 704
Out of 5,152 analysts
15
Total ratings
84.62%
Success rate
20.7%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Debanjana Chatterjee

Intellia Therapeutics
Mar 4, 2026
Upgrades: Buy
Price Target: $29
Current: $13.15
Upside: +120.53%
Armata Pharmaceuticals
Jan 5, 2026
Initiates: Buy
Price Target: $15
Current: $10.96
Upside: +36.86%
Spyre Therapeutics
Dec 1, 2025
Upgrades: Buy
Price Target: $64
Current: $40.59
Upside: +57.67%
Sionna Therapeutics
Sep 8, 2025
Initiates: Buy
Price Target: $46
Current: $34.56
Upside: +33.10%
Theravance Biopharma
Jun 17, 2025
Initiates: Buy
Price Target: $24
Current: $13.58
Upside: +76.73%
Sagimet Biosciences
Jun 6, 2025
Maintains: Buy
Price Target: $15$27
Current: $5.45
Upside: +395.41%
Tvardi Therapeutics
Apr 28, 2025
Initiates: Buy
Price Target: $39
Current: $4.02
Upside: +870.15%
KalVista Pharmaceuticals
Mar 26, 2025
Maintains: Buy
Price Target: $30
Current: $16.21
Upside: +85.07%
Contineum Therapeutics
Mar 13, 2025
Initiates: Buy
Price Target: $23
Current: $13.81
Upside: +66.55%
Pharvaris
Sep 19, 2024
Initiates: Buy
Price Target: $46
Current: $25.84
Upside: +78.02%